Follow the Novan, Inc. stock price and the full directors' dealings record of the company, a listed issuer based in United States. Shares are quoted on US US, under the supervision of SEC (Form 4). Operating in the Health Care sector, Novan, Inc. has logged 13 public disclosures. Market capitalisation: €5.5bn. The latest transaction was reported on 27 June 2023 (Cession). Among the most active insiders: BIERMAN JAMES L. The full history is openly available.
13
Insider Decl.
0
Thresholds
€63,865
6 ops.
Buy Volume
€4,304
1 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Novan, Inc. Strong Buy (bullish), based on 2 analysts. Average price target: US$171.50.
51Σ signal
Buys €63,865€4,304 Sells
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 14,771 of 25,564 companies
47.3
score / 100
Value
41
Quality
54
FCF yld0.9%
Earn yld1.0%
EV/EBITDA·
ROE5.2%
Gross mgn44%
Net mgn5.5%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.